Market report search

Results for “Diagnostics”

20 reports match your search. Review the report scope or download a free sample.

Available reports

Explore matching market intelligence

20 results
Syndicated Report ID 15701

Metagenomics Market Size, Share & Industry Analysis, By Type (Sequencing, Bioinformatics), By Application (Clinical Diagnostics, Microbiome Research, Environmental Monitoring, Agriculture and Food Safety), By End User (Clinical Laboratories, Academic Research Institutions, Biopharmaceutical Companies, Government and Environmental Agencies), By Sequencing Workflow (Amplicon Metagenomics, Shotgun Short-Read Metagenomics, Long-Read and Genome-Resolved Metagenomics), and Regional Forecast, 2026-2034

Global Metagenomics market was valued at USD 229 million in 2024 and is projected to reach USD 447 million by 2031, at a CAGR of 10.3% during the forecast period

26 Oct 2026 119 Pages
View Report Free Sample
Syndicated Report ID 13898

Phosphate Buffered Saline Pbs Tablet Market Size, Share & Industry Analysis, By Type (100 mL / 200 mL Preparation Tablets, 500 mL Preparation Tablets, 1,000 mL / Other Formats), By Application (Cell Culture, Immunoassays & ELISA, Molecular Biology, Histology & Diagnostics, Other Laboratory Uses), By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs / CDMOs), By Product Formulation (Standard PBS, PBS-Tween, Specialty / Low-Ionic-Strength PBS), By Packaging (Bottle Packs, Blister / Individual Packs, Bulk Laboratory Packs), and Regional Forecast, 2026-2034

Global Phosphate Buffered Saline Tablet market was valued at USD 120 million in 2024 and is projected to reach USD 210 million by 2032, at a CAGR of 7.3%.

05 Oct 2026 129 Pages
View Report Free Sample
Syndicated Report ID 15615

Head And Neck Cancer Diagnostics Market Size, Share & Industry Analysis, By Type (Biopsy & Blood Tests, Imaging, Endoscopy, Dental Diagnostics), By Application (Oral Cavity & Oropharyngeal Cancer, Laryngeal & Hypopharyngeal Cancer, Nasopharyngeal Cancer, Salivary Gland & Sinonasal Cancer), By End User (Hospitals, Specialty Cancer Clinics, Diagnostic Imaging Centers, Pathology & Molecular Laboratories), By Diagnostic Stage (Initial Detection, Histologic Confirmation, Staging & Treatment Planning, Recurrence / Surveillance), By Technology (Histopathology & IHC, HPV/EBV Molecular Testing, CT/MRI/PET Imaging, Digital Pathology & AI-Assisted Diagnostics), and Regional Forecast, 2026-2034

Head and Neck Cancer Diagnostics market valued at USD 1.85?billion in 2024, projected to reach USD 3.47?billion by 2032, at a CAGR of 7.1% during the forecast period.

28 Sep 2026 78 Pages
View Report Free Sample
Syndicated Report ID 17138

AI Imaging & Diagnostics Market Size, Share & Industry Analysis, By Type (Imaging-Based AI, Signal-Based Diagnostics, Multimodal Diagnostic AI), By Application (Disease Detection & Triage, Image Segmentation & Quantification, Clinical Risk Classification, Diagnostic Recommendations), By Deployment & Delivery (Cloud & SaaS, On-Premise Software, Device-Embedded AI), By Clinical Specialty (Radiology, Cardiology, Oncology & Pathology, Ophthalmology & Other), and Global Forecast, 2026-2034

19 Oct 2026 171 Pages
View Report Free Sample
Syndicated Report ID 15638

IVD (In Vitro Diagnostic) Testing Market Size, Share & Industry Analysis, By Product Type (Reagents and Test Consumables, Diagnostic Instruments, Controls and Calibrators, Dedicated Diagnostic Software), By Testing Technology (Immunoassay and Clinical Chemistry, Molecular Diagnostics, Hematology and Coagulation, Microbiology and Other), By Clinical Application (Infectious Diseases, Chronic and Metabolic Diseases, Oncology and Precision Medicine, Women?s Health and Other), By Customer Setting (Hospital Laboratories, Independent Reference Laboratories, Physician Office and Point-of-Care, Public Health and Other), and Global Forecast, 2026-2034

Global IVD Testing market was valued at USD 15.39 billion in 2024 and projected to reach USD 25.68 billion by 2031, at a CAGR of 7.8%.

20 Oct 2026 78 Pages
View Report Free Sample
Syndicated Report ID 15764

Skin Cancer Diagnostics Market Size, Share & Industry Analysis, By Type (Basal Cell Carcinoma, Squamous Cell Carcinoma, Malignant Melanoma, Others), By Application (Hospitals, Clinics, Laboratories, Others), By End User (Dermatologists, General Practitioners, Oncologists), By Technology (Dermoscopy, Biopsy Techniques, Imaging Systems, AI-Assisted Diagnostics), and Regional Forecast, 2026-2034

Global skin cancer diagnostics market was valued at USD 1.29B in 2024 and is projected to reach USD 1.92B by 2031, at a CAGR of 6.0% during the forecast period

26 Oct 2026 87 Pages
View Report Free Sample